Safety Without Compromise: IKA Launches the Next Evolution of Magnetic Stirring
May 19, 2026
Engineered with the "Integrated Safety" concept and 100% tested via the automated RoboMAG production line, IKA’s new stirrers set a new global standard for laboratory protection IKA’s new generation of magnetic stirrers incorporates state-of-the-art smart features, setting the new global standards for efficiency, safety, and reliability. The Legacy of IKA IKA launched its first generation [...]
Genedata Introduces AI-Native CMC Platform to Accelerate Drug Development and Manufacturing
May 19, 2026
Co-developed with top 10 pharmas, Genedata Vico drives insight and decision-making in CMC, winning Bio-IT World award. Basel, Switzerland — Genedata, a Danaher company, and the leading provider of enterprise software solutions for biopharma R&D, today announced the launch of Genedata Vico™, an AI native solution to accelerate CMC processes by enabling data-driven experimentation, process [...]
EpiCypher and New England Biolabs Expand Strategic Partnership to Advance Epigenomics Research
May 19, 2026
DURHAM, N.C. and IPSWICH, Mass. -- EpiCypher® and New England Biolabs® (NEB®) today announced an expanded strategic partnership to co-develop next-generation tools for epigenomics research. Building on a successful track record of collaboration, the partnership will accelerate the creation of innovative technologies that advance understanding of gene regulation, chromatin biology, and disease mechanisms. The partnership combines EpiCypher's strengths [...]
NGI Becomes First Certified Core Lab and Service Provider for Epigenica’s EpiFinder™ Platforms
May 19, 2026
Stockholm, Sweden -- Epigenica AB, a company commercializing advanced tools for epigenetic analysis, today announced an agreement with the National Genomics Infrastructure (NGI), one of the largest technical platforms at SciLifeLab. NGI Stockholm has become the first official core laboratory and service provider globally to offer Epigenica’s EpiFinder™ platform. This milestone represents a significant step in [...]
Avantor® Announces Gerard (Jerry) Porreca as Executive Vice President, Quality and Regulatory
May 19, 2026
RADNOR, Pa. -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today announced that Gerard (Jerry) Porreca has joined the company as Executive Vice President, Quality and Regulatory. In this role, Mr. Porreca is responsible for leading quality assurance, quality systems [...]
May 19, 2026
MONMOUTH JUNCTION, N.J. -- TheWell Bioscience, a biotechnology company pioneering advanced 3D cell culture technologies, today announced the launch of its RocketCell™ Organoid Xeno-Free Essential-Core Medium, a chemically defined, universal foundation medium designed to streamline organoid culture workflows while enhancing reproducibility, scalability, and cost efficiency. As organoid models continue to expand across disease modeling, drug discovery, and precision [...]
28bio Launches CNS-3D Inflammatory Organoids to Predict Anti-inflammatory Therapeutic Efficacy
May 19, 2026
The only assay-ready immunocompetent 3D brain organoid model incorporating microglia for studies of neuroinflammatory mechanisms and drug efficacy Expands the ability to model human pathogenesis and functional recovery for neurodegenerative diseases NEW ORLEANS -- 28bio today announced CNS-3D Inflammatory Organoids, designed to evaluate efficacy of anti-inflammatory drugs by quantifying their ability to reduce inflammatory injury, preserve tissue health, [...]
May 19, 2026
OmicsHQ brings together comprehensive, expertly curated, standardized multi-omics datasets from across the scientific ecosystem, complete with pre-processed datasets ready to accelerate research, drug-discovery, and AI-driven innovation. SAN DIEGO -- Today Rancho BioSciences, the premier tech-enabled data science partner for biopharma, announced the launch of OmicsHQTM, a unified catalog of expertly curated, standardized multi-omics datasets designed for immediate [...]
May 19, 2026
Collaboration with PacBio will generate long-read bulk RNA-seq data to advance patient-level prediction from tumor transcriptomes SAN FRANCISCO -- Blank Bio, an applied AI research lab training foundation models for RNA, today announced the closing of a $7.2 million seed financing and a strategic collaboration with Pacific Biosciences (Nasdaq: PACB), a leading developer of high-quality, [...]
May 19, 2026
Company appoints Sam Ropp as Chief Commercial Officer and Susan Tousi to Board of Directors BOSTON -- Atrandi Biosciences, a life science tools company pioneering Semi-Permeable Capsule (SPC) technology for single-cell and multiomics research, today announced the appointment of Sam Ropp, PhD, as Chief Commercial Officer and Susan Tousi as Chairman of the Board of Directors. [...]

